Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	52.10	59.06	38.83
Graham Fair Price	-10.37	3.83	4.27
PEG	76.29	-0.65	-2.73
Price/Book	-7.79	2.43	2.63
Price/Cash Flow	8346.34	333.96	-3.95
Prices/Earnings	24.21	15.42	12.42
Price/Sales	14.99	16.19	14.08
Price/FCF	8346.34	333.96	-3.95
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.76	0.57	0.52
Operating Margin	-21.66	0.31	0.39
ROA	-28.65	0.02	0.02
ROE	0.05	0.04	-25.76
ROIC	0.03	0.02	-40.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	0.23	-57.63
Dividends QOQ	0.73	0.16	-77.97
EBIT QOQ	0.19	-0.35	84.38
EPS QOQ	-0.05	-0.24	-423.81
FCF QOQ	-7.21	1.01	-85.97
Revenue QOQ	0.05	-0.16	208.65
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	83.70	121.64	45.34
Days Sales Outstanding (DSO)	34.13	35.21	3.17
Inventory Turnover	1.08	0.74	-31.20
Debt/Capitalization	0.52	0.53	2.54
Quick Ratio	0.17	0.29	72.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.91	4.07	4.03
Cash	0.22	0.72	235.27
Capex	-2.98	-0.17	94.40
Free Cash Flow	-2.60	0.03	-98.86
Revenue	0.73	0.61	-16.58
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.29	0.43	49.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.77	16.26	50.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating